73.60USD-3.99%Mkt Cap: 10.03B USDP/E: —Last update: 2026-06-01
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the Unit…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap10.03B USD
Enterprise Value10.18B USD
Revenue (TTM)105.81M USD
Gross Profit-327.99M USD
Net Income (TTM)-784.96M USD
Revenue/Share0.8720 USD
Last Price73.60 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees673
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.15
PEG—
EV/EBITDA-16.18
EV/Revenue96.17
P/S98.49
P/B-11.54
EPS (TTM)-6.85
EPS (Forward)-4.75
52W Range
30.2687% of range80.20
52W High80.20 USD
52W Low30.26 USD
Profitability
Gross Margin-372.55%
Oper. Margin-948.69%
EBITDA Margin0.00%
Profit Margin-891.60%
ROE119.00%
ROA-55.10%
Growth
Revenue Growth1125.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-510.01M USD
CapEx (TTM)24.81M USD
FCF Margin-360.12%
FCF Yield-3.80%
Net Debt625.07M USD
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity-1.95
Current Ratio4.21
Quick Ratio4.14
Book Value/Sh-6.6530 USD
Cash/Share6.578 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJun 25, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)104.70 USD
Target Range69.00 USD – 146.00 USD
# Analysts20
Ownership
Shares Out.135.77M
Float123.93M
Insiders0.72%
Institutions118.99%
Short Interest
Short Ratio5.0d
Short % Float18.75%
Short % Out.12.12%
Shares Short16.46M
Short (prev mo.)14.89M
Technical
SMA 5068.38 (+7.6%)
SMA 20061.18 (+20.3%)
Beta0.38
S&P 52W Chg27.94%
Avg Vol (30d)2.88M
Avg Vol (10d)1.89M
Technical Indicators
RSI (14)58.3
MACD2.6843
MACD Signal2.9242
MACD Hist.-0.2400
BB Upper83.12 USD
BB Middle75.34 USD
BB Lower67.56 USD
BB Width20.66%
ATR (14)2.888 USD
Vol Ratio (20d)0.25x